Biotech · Public company · Los Angeles, CA, US
Immix Biopharma, Inc.
Ticker IMMX · SEC CIK 0001873835
Track this companyFree. Adds Immix Biopharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Clinical trials1
- Study of NXC-201 CAR-T in Patients With Light Chain (AL) AmyloidosisPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 5, 2024ClinicalTrials.gov NCT06097832 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 21, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 21, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 10-K/A · 10-K/ASEC EDGAR · filed Mar 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 25, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 25, 2026 · fetched Nov 12, 2026